# IOVANCE BIOTHERAPEUTICS, INC. (IOVA) FY2026 Q2 Balance Sheet

- Company: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001104659-26-091716
- Page: https://plicit.ai/financials/iova/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/iova-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 915,531,000 US dollars
- **Current assets**: 464,257,000 US dollars
- **Non-current assets**: 451,274,000 US dollars
- **Liabilities**: 179,486,000 US dollars
- **Current liabilities**: 106,848,000 US dollars
- **Non-current liabilities**: 72,638,000 US dollars
- **Equity**: 736,045,000 US dollars
- **Short-term investments**: 186,906,000 US dollars
- **Cash and cash equivalents**: 110,768,000 US dollars
- **Trade accounts receivable**: 102,119,000 US dollars
- **Inventory**: 55,590,000 US dollars
- **Prepaid expenses and other assets**: 8,874,000 US dollars
- **Intangible assets, net**: 263,894,000 US dollars
- **Property and equipment, net**: 131,464,000 US dollars
- **Operating lease right-of-use assets**: 43,480,000 US dollars
- **Long-term assets**: 6,431,000 US dollars
- **Restricted cash**: 6,005,000 US dollars
- **Accrued expenses and other liabilities**: 77,964,000 US dollars
- **Accounts payable**: 26,211,000 US dollars
- **Operating lease liabilities**: 2,673,000 US dollars
- **Operating lease liabilities - non-current**: 43,330,000 US dollars
- **Deferred tax liabilities**: 29,308,000 US dollars
- **Additional paid-in capital**: 3,624,836,000 US dollars
- **Accumulated other comprehensive income**: 13,078,000 US dollars
- **Common stock, $0.000041666 par value; 650,000,000 shares authorized, 452,971,016 and 411,938,061 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 19,000 US dollars
- **Preferred stock, Value - Series B Convertible Preferred Stock**: 2,000 US dollars
- **Accumulated deficit**: negative 2,901,890,000 US dollars
- **Gross equity (calculated)**: 3,637,935,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.